AllianceBernstein’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
DC
OFM
LCM
DFO
AllianceBernstein's NUVB Position: Q2 2026 in Review
AllianceBernstein increased its Nuvation Bio (NUVB) stake by 13% in Q2 2026, buying an estimated $155K and bringing the position to 269,203 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #2324.
AllianceBernstein first reported a position in NUVB in Q2 2021 and has held it in 21 quarters since. The position peaked at $2.13M in Q1 2026. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.
- AllianceBernstein held 269,203 shares of Nuvation Bio worth $1.15M as of Q2 2026.
- AllianceBernstein bought 31,700 Nuvation Bio shares in Q2 2026, an estimated $155K.
- Nuvation Bio made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2324 holding.
- AllianceBernstein first reported a position in Nuvation Bio in Q2 2021 and has held it in 21 quarters since.
- AllianceBernstein's Nuvation Bio position peaked at $2.13M in Q1 2026.
- 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.